Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Autonomic Neuroscience : Basic & Clinical|January 10, 2026
From lab to life: Wearables, real-world data, and the future of autonomic researchJulien Rimok, Kelly A Larkin-KaiserPhysical Medicine and Rehabilitation Clinics of North America|March 21, 2024
Technological Advances in Stroke Rehabilitation: Robotics and Virtual RealityDeepthi Rajashekar, Alexa Boyer, Kelly A Larkin-Kaiser, et al.The Journal of Spinal Cord Medicine|November 17, 2023
Knowledge and awareness assessment of bone loss and fracture risk after spinal cord injuryLaura E Crack, Kelly A Larkin-Kaiser, Aaron A Phillips, et al.Journal of Athletic Training|November 15, 2014
Near-infrared light therapy to attenuate strength loss after strenuous resistance exerciseKelly A Larkin-Kaiser, Evangelos Christou, Mark Tillman, et al.Journal of Athletic Training|February 7, 2015
Range of motion as a predictor of clinical shoulder pain during recovery from delayed-onset muscle sorenessKelly A Larkin-Kaiser, Jeffrey J Parr, Paul A Borsa, et al.Future Oncology (London, England)|July 13, 2019
Systematic review and network meta-analysis of first-line therapy for advanced EGFR-positive non-small-cell lung cancerJacob Franek, Joseph C Cappelleri, Kelly A Larkin-Kaiser, et al.Mitochondrion|November 20, 2013
Effect of near-infrared light exposure on mitochondrial signaling in C2C12 muscle cellsLinda M-D Nguyen, Angelina G Malamo, Kelly A Larkin-Kaiser, et al.Journal of Physical Activity & Health|July 27, 2025
Understanding Physical Activity Facilitated by a Single Session of Robotic Walking for Children and Small Adults Living With Severe Mobility ImpairmentsJessica L Youngblood, Benjamin M Norman, Sean P Dukelow, et al.Journal of Neuroengineering and Rehabilitation|December 13, 2025
Overground robotic walker use in the home and community: a six-month prospective cohort studyAlicia J Hilderley, Christa M Diot, Hua Shen, et al.Future Oncology (London, England)|September 2, 2020
Network meta analysis of first-line therapy for advanced EGFR mutation positive non-small-cell lung cancer: updated overall survivalMeganS Farris, Kelly A Larkin-Kaiser, Tayler Scory, et al.Pageof 3